Campbell Newman Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Campbell Newman Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-21,010	Closed	-$1.3M	–	119
2022 Q3	$1.3M	Buy	21,010 +500	+2%	+$34.9K	0.15%	65
2022 Q2	$1.64M	Buy	20,510 +901	+5%	+$85.3K	0.17%	57
2022 Q1	$2.06M	Buy	19,609 +369	+2%	+$36K	0.2%	54
2021 Q4	$2.07M	Sell	19,240 -9,138	-32%	-$997K	0.18%	58
2021 Q3	$3.11M	Buy	28,378 +1,494	+6%	+$155K	0.32%	42
2021 Q2	$2.52M	Buy	26,884 +1,385	+5%	+$127K	0.25%	50
2021 Q1	$2.35M	Buy	25,499 +1,220	+5%	+$103K	0.25%	52
2020 Q4	$1.78M	Buy	24,279 +1,834	+8%	+$136K	0.2%	55
2020 Q3	$1.74M	Sell	22,445 -9,006	-29%	-$620K	0.22%	52
2020 Q2	$1.75M	Buy	31,451 +311	+1%	+$13.3K	0.24%	49
2020 Q1	$922K	Sell	31,140 -1,739	-5%	-$58.8K	0.16%	61
2019 Q4	$1.19M	Buy	32,879 +224	+0.7%	+$6.87K	0.16%	62
2019 Q3	$889K	Sell	32,655 -247	-0.8%	-$6.39K	0.13%	71
2019 Q2	$792K	Buy	32,902 +2,217	+7%	+$56.2K	0.12%	75
2019 Q1	$811K	Buy	30,685 +11,821	+63%	+$280K	0.13%	73
2018 Q4	$369K	Buy	+18,864	New	+$370K	0.06%	110

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Campbell Newman Asset Management's HZNP Position: Q4 2022 in Review

Campbell Newman Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 21,010 shares — an estimated $1.3M sold.

Campbell Newman Asset Management first reported a position in HZNP in Q4 2018 and held it in 16 quarters. The position peaked at $3.11M in Q3 2021. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

Campbell Newman Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Campbell Newman Asset Management sold 21,010 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $1.3M.
Campbell Newman Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2018 and held it in 16 quarters.
Campbell Newman Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.11M in Q3 2021.
615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Campbell Newman Asset Management's 13F filing for Q4 2022, filed 26 Jan 2023.